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A new system, Micronaut-Candida, was compared to API ID32C to identify 264 yeast (Candida albicans, C.
parapsilosis, C. tropicalis, C. krusei, C. inconspicua, C. norvegensis, C. lusitaniae, C. guilliermondii, C. dubliniensis,
C. pulcherrima, C. famata, C. rugosa, C. glabrata, C. kefyr, C. lipolytica, C. catenulata, C. neoformans, Geotrichum
and Trichosporon species, Rhodotorula glutinis, and Saccharomyces cerevisiae) clinical isolates. Results were in
concordance in 244 cases. Eighteen out of the 20 of discordant results were correctly identified by Micronaut-
Candida but not by API ID32C, as confirmed by PCR ribotyping.
The frequency of invasive fungal infections has increased
dramatically during the past 3 decades (10). Correct identifi-
cation is important for accurate therapy, as some fungi possess
intrinsic resistance to certain antifungals (4). Conventional
methods are time-consuming, while DNA-based methods are
not available to all laboratories. Relatively simple tests based
on assimilation reactions (API ID32C, API 20C, API Candida)
are commercially available, though they may sometimes yield
equivocal results or even lead to misidentification (1, 3, 5, 11).
A new microplate-based system with four tests on a single
plate, Micronaut-Candida (Merlin Diagnostika GmbH, Born-
heim, Germany), has been developed to identify medically
important yeasts. Its database contains 31 species of six genera.
A test contains 21 biochemical reactions and three controls (8
chromogenic substrates [N-acetyl--D-galactosaminidase, -ga-
lactosidase, L-prolinaminopeptidase, p-nitrophenyl--glucoroni-
dase, L-phenylalaninaminopeptidase, -glucosidase, and -gluco-
sidase plus control], 14 carbohydrate assimilation tests [melibiose,
D-xylose, L-rhamnose, gentibiose, D-glucose, inositol, cellobiose,
saccharose, trehalose, galactose, maltose, lactose, raffinose, and
assimilation control], and urease test with its control). After 24 h,
results are read and interpreted automatically using the Micro-
naut Skan device and the Micronaut software.
(This work was presented in part at the 16th Congress of the
International Society for Human and Animal Mycology, Paris,
France, 2006 [13a].)
The aim of our study was to identify 264 yeast clinical iso-
lates with Micronaut-Candida and with API ID32C (Bio-
Merieux, Marcy l’Etoile, France). We also tested 13 ATCC
strains (Candida albicans 14053, C. albicans 10231, C. parapsi-
losis 22019, C. tropicalis 750, C. krusei 6258, C. inconspicua
16783, C. norvegensis 22977, C. lusitaniae 38533, C. guilliermon-
dii 6260, C. dubliniensis CD36, C. pulcherrima 18406, C. famata
36239, and C. rugosa 2142). The majority of isolates were
isolated from throat, sputum, blood, wound, urine, and vagina
from in- and outpatients between November 2005 and April
2006. All C. parapsilosis isolates belonged to C. parapsilosis
sensu stricto, determined as described earlier (13). Candida
dubliniensis isolates were derived from a previous study (12).
Some less common yeast species (Geotrichum and Trichos-
poron species) were from our collection.
Yeasts grown on Sabouraud dextrose agar were tested si-
multaneously with API ID32C and Micronaut-Candida accord-
ing to the manufacturers’ instructions. API ID32C and Micro-
naut-Candida were read after 48 and 24 h, respectively. In case
of discrepancy, both methods were repeated. If these were in
accord, we accepted them as final. Otherwise or when addi-
tional tests (microscopic morphology, esculin hydrolysis,
growth at 45°C, nitrate assimilation) yielded equivocal results,
PCR ribotyping was performed in each case and ribotyping
results were accepted as valid identification (5).
The proportion of misidentifications was determined for
each test and the relative accuracies of results were compared
using Fisher’s exact test.
API ID32C correctly identified all tested ATCC strains. Mi-
cronaut-Candida misidentified C. norvegensis and C. rugosa
ATCC strains, both as C. valida according to the additional test
proposed (microscopic morphology). As C. pulcherrima is not
included in the Micronaut database, Micronaut could not iden-
tify the C. pulcherrima ATCC strain. Other ATCC strains were
correctly identified.
Results obtained by both methods without additional tests
were in concordance for C. albicans (n  40), C. glabrata (n 
40), C. parapsilosis (n 35), C. tropicalis (n 35), C. krusei (n
35), C. kefyr (n  10), C. dubliniensis (n  9), C. guilliermondii
(n 7), C. lusitaniae (n 7), C. lipolytica (n 4), S. cerevisiae,
(n  8), C. famata (n  2), C. catenulata (n  2), C. rugosa (n 
1), C. neoformans (n  2), and Geotrichum (n  2) and Tricho-
sporon (n  2) species isolates. In the cases of one of two C.
rugosa and two of two Rhodotorula glutinis isolates, Micronaut-
Candida needed additional tests (microscopic morphology and
nitrate assimilation, respectively) to accord with API ID32C.
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API ID32C using an extra test (esculin hydrolysis) misiden-
tified all tested C. inconspicua strains (n 12) as C. norvegensis
strains, as confirmed by PCR ribotyping (6). These strains were
correctly identified with Micronaut-Candida using an addi-
tional test (microscopic morphology). Five C. lusitaniae strains
were misidentified as C. famata and a single C. tropicalis strain
was misidentified as C. humicolus with API ID32C but not with
Micronaut-Candida. Two C. pulcherrima clinical isolates were
correctly identified with API ID32C; Micronaut-Candida did
not identify these strains, as C. pulcherrima is not included in
the Micronaut database. These identities were also confirmed
by PCR ribotyping.
Micronaut-Candida correctly identified Candida species oc-
curring frequently in clinical practice (C. albicans, C. glabrata,
C. parapsilosis, C. tropicalis, and C. krusei) within 24 h. Addi-
tionally, Candida species possessing primary (C. krusei) or sec-
ondary (C. glabrata) resistance to fluconazole (6, 9) were also
identified accurately within 1 workday. Both methods correctly
identified all tested C. dubliniensis isolates without additional
tests. As C. dubliniensis, similarly to C. glabrata, may acquire
fluconazole resistance readily during treatment (7), correct
differentiation of this species from C. albicans within 24 h can
be important.
API ID32C but not Micronaut-Candida misidentified 5 of 12
C. lusitaniae strains as C. famata strains. This may be prob-
lematic in clinical situations, as C. famata, in contrast to C.
lusitaniae, often shows high MICs to triazoles and caspofungin
(2, 8), while C. lusitaniae may be resistant to amphotericin B (4).
Micronaut-Candida never misidentified C. inconspicua, but
an extra test (microscopic morphology) and extra days were
needed to properly identify this inherently fluconazole-resis-
tant species (5). Thus, fast and correct identification of C.
inconspicua remains unresolved.
In summary, only 2 clinical isolates were unidentified/misi-
dentified by Micronaut-Candida, while 18 were unidentified/
misidentified by API ID32C (0.76% versus 6.82%; P  0.001).
Micronaut-Candida is an easy-to-perform method to identify
the most common Candida species within 24 h. Micronaut-
Candida without extra tests identified 241 (91.3%) yeast iso-
lates concordantly to API ID32C. In case of the 18 discordant
isolates, ribotyping confirmed the Micronaut-Candida results.
Rare species with proven decreased susceptibility to certain
antifungals (2, 5, 8, 10) were identified correctly by Micronaut-
Candida with (C. inconspicua) or without extra tests (C. kefyr,
C. guilliermondii, and C. lusitaniae). Thus, this new system
seems to be a reliable and useful method for identification of
medically relevant yeasts in routine mycology laboratories.
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